Sarana Meditama Metropolitan (SAME) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Based on the latest financial reports, Sarana Meditama Metropolitan (SAME) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp157.73 Billion ≈ $9.24 Million USD) by net assets (Rp4.17 Trillion ≈ $244.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sarana Meditama Metropolitan - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Sarana Meditama Metropolitan's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sarana Meditama Metropolitan total liabilities for a breakdown of total debt and financial obligations.

Sarana Meditama Metropolitan Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sarana Meditama Metropolitan ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Samudera Indonesia Tbk
JK:SMDR
-0.044x
Ratchthani Leasing Public Company Limited
BK:THANI
0.127x
Mount Gibson Iron Ltd
AU:MGX
0.026x
Motech Industries Co Ltd
TWO:6244
0.132x
T&L Co. Ltd
KQ:340570
0.049x
Regional Management Corp
NYSE:RM
0.232x
Omni Bridgeway Ltd
AU:OBL
0.027x
Lifezone Metals Limited
NYSE:LZM
-0.061x

Annual Cash Flow Conversion Efficiency for Sarana Meditama Metropolitan (2011–2025)

The table below shows the annual cash flow conversion efficiency of Sarana Meditama Metropolitan from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Sarana Meditama Metropolitan worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp4.17 Trillion
≈ $244.10 Million
Rp357.02 Billion
≈ $20.92 Million
0.086x +34.64%
2024-12-31 Rp4.14 Trillion
≈ $242.49 Million
Rp263.42 Billion
≈ $15.44 Million
0.064x +67.33%
2023-12-31 Rp3.98 Trillion
≈ $233.42 Million
Rp151.55 Billion
≈ $8.88 Million
0.038x +1481.24%
2022-12-31 Rp3.98 Trillion
≈ $233.39 Million
Rp9.58 Billion
≈ $561.51K
0.002x -95.80%
2021-12-31 Rp4.43 Trillion
≈ $259.67 Million
Rp253.74 Billion
≈ $14.87 Million
0.057x +244.24%
2020-12-31 Rp545.82 Billion
≈ $31.98 Million
Rp-21.67 Billion
≈ $-1.27 Million
-0.040x -120.60%
2019-12-31 Rp977.50 Billion
≈ $57.28 Million
Rp188.40 Billion
≈ $11.04 Million
0.193x +716.24%
2018-12-31 Rp1.33 Trillion
≈ $77.70 Million
Rp31.31 Billion
≈ $1.83 Million
0.024x -62.85%
2017-12-31 Rp1.04 Trillion
≈ $61.07 Million
Rp66.26 Billion
≈ $3.88 Million
0.064x -56.32%
2016-12-31 Rp850.97 Billion
≈ $49.86 Million
Rp123.85 Billion
≈ $7.26 Million
0.146x +10.60%
2015-12-31 Rp741.18 Billion
≈ $43.43 Million
Rp97.53 Billion
≈ $5.71 Million
0.132x -77.37%
2014-12-31 Rp191.08 Billion
≈ $11.20 Million
Rp111.12 Billion
≈ $6.51 Million
0.582x +3.41%
2013-12-31 Rp133.01 Billion
≈ $7.79 Million
Rp74.80 Billion
≈ $4.38 Million
0.562x -80.36%
2012-12-31 Rp19.22 Billion
≈ $1.13 Million
Rp55.04 Billion
≈ $3.23 Million
2.863x +137.81%
2011-12-31 Rp-4.05 Billion
≈ $-237.07K
Rp30.64 Billion
≈ $1.80 Million
-7.573x --

About Sarana Meditama Metropolitan

JK:SAME Indonesia Medical Care Facilities
Market Cap
$333.92 Million
Rp5.70 Trillion IDR
Market Cap Rank
#14511 Global
#180 in Indonesia
Share Price
Rp332.00
Change (1 day)
-2.92%
52-Week Range
Rp246.00 - Rp428.00
All Time High
Rp755.00
About

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. It also is involved in trading of medical equipment; healthcare pharmacy; real estate; and agriculture. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.